Page results
-
UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.
-
Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study at UCLH and UCL has found.
-
Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the wellbeing of doctors.
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
-
Johanna Moss was appointed to the Board on 7 January 2025 as the director of strategy. Prior to this Jo was the chief strategy and transformation officer for the North East London Integrated Care Board and she also held the role of director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust for seven years, where she was the lead for their major capital project to build a new hospital and research centre in Camden.
-
Carlito Adan - Deputy Lead Nurse Clinical Research Facility
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
UCLH has recruited the first patient to a global trial of an investigational medication for adults with Huntington’s Disease (HD).
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements